The Latest Cardiac and Vascular News
RIDGEFIELD, Conn. and INDIANAPOLIS, July 19, 2018 /PRNewswire/ — CARMELINA® (CArdiovascular safety and Renal Microvascular outcomE with LINAgliptin in patients with type 2 diabetes at high vascular risk) met its primary endpoint, defined as time to first occurrence of cardiovascular death, non-fatal myocardial infarction or non-fatal stroke (3-point MACE), with Tradjenta® demonstrating similar cardiovascular safety compared with […]
STAMFORD, Conn., July 19, 2018 /PRNewswire/ — (Booth 106) — FUJIFILM Medical Systems U.S.A., Inc., a leading provider of Enterprise Imaging and Informatics solutions, will demonstrate Synapse® Cardiovascular, its comprehensive enterprise solution for cardiology, at the World Society for Pediatric and Congenital Heart Surgery’s (WSPCHS) 6thscientific meeting. This meeting is the premier gathering of the largest professional […]
BETHLEHEM, Pa., July 19, 2018 (GLOBE NEWSWIRE) — B. Braun Medical Inc. (B. Braun), a market leader in renal therapies, infusion therapy, and pain management, has signed an agreement to acquire the bloodlines business operated under the Medisystems® name by NxStage Medical, Inc. (Nasdaq:NXTM), a medical technology company based in Lawrence, […]
SEATTLE, July 16, 2018 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor (“CAM™”), the world’s first P-wave centric™ ambulatory cardiac monitor and arrhythmia detection device, announced today it has raised additional growth capital from its existing equity […]
LOS ANGELES–(BUSINESS WIRE)–Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced Jeremiah Stone’s appointment as the Company’s Chief Technology Officer, a newly created position within the Company. He will be responsible for the strategic direction and evolution of Catasys’ global technology operations, including […]
CALGARY, Alberta, July 18, 2018 (GLOBE NEWSWIRE) — Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE:HEM) is pleased to announce that it has treated three additional patients including its first two patients in the United States under its continuing Phase II Clinical Trial for critical limb ischemia (“CLI”). The first […]
ABBOTT PARK, Ill., July 18, 2018 /PRNewswire/ — Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2018. Second-quarter worldwide sales of $7.8 billion increased 17.0 percent on a reported basis and 8.0 percent on an organic* basis. Reported diluted EPS from continuing operations under GAAP was $0.40 in the second quarter. Adjusted diluted EPS […]
ATLANTA, July 18, 2018 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2018 second quarter financial results will be released on Monday, August 6, 2018 after the market closes. On Tuesday, August 7, 2018 the Company will hold a teleconference call and live webcast at 8:30 […]
INDIANAPOLIS, July 18, 2018 /PRNewswire/ — Cook Regentec announced today the first clinical use in the United Statesof the Advance CS Coronary Sinus Infusion Catheter and Compass® CT Disposable Pressure Transducer to deliver a therapeutic in heart failure patients. The Advance CS Coronary Sinus Infusion Catheter is a percutaneous balloon infusion catheter designed […]
BERLIN–(BUSINESS WIRE)–OMEICOS Therapeutics, a Berlin-based biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular and ophthalmic diseases, today announced results from its first-in-human clinical study for OMT-28. The study met its primary goal with OMT-28 exhibiting an excellent tolerability profile and showing no safety signals […]
